Truth, Inspiration, Hope.

NEWS

Republicans and Democrats are at loggerheads when it comes to raising the debt ceiling.
Biden May Counter Filibuster to Raise Debt Ceiling, Republicans Wary of ‘Socialist’ Infrastructure Bill
President Joe Biden has said that Democrats might make an exception to the filibuster rule to pass legislation...
Trading of Evergrande Shares Halted; Worries Concerning Chinese Property Market Deepen
On Oct. 4, Evergrande halted trading of its shares on the Hong Kong Stock Exchange (HKSE) pending a “...
Lt. Col. Stuart Scheller Charged With Six Violations Ahead of Court-Martial
Lt. Col. Stuart Scheller has been granted a conditional release from military jail and is now charged...
Senate Reaches Agreement to Raise National Debt Ceiling
On Oct. 7, The U.S. Senate agreed, as expected, to a provisional increase in the national debt ceiling...
Pfizer Expects FDA Approval to Vaccinate Children Under 12 by Halloween
Pharma giant Pfizer/BioNTech announced on Thursday that the company is seeking FDA approval for its COVID...
People wait in line for COVID-19 vaccines at Kedren Community Health Center on January 25, 2021 in Los Angeles, California. A new study by a Harvard and a Turner Fenton scientist published in the European Journal of Epidemiology has found “no discernible relationship” between vaccine acceptance rate and increasing positive PCR test count in 68 countries and 2947 U.S. counties.
‘No Discernable Relationship’ Between Vaccination Rate and New COVID-19 Cases Across 68 Countries: Study
A recent study examining data across 68 countries, including 2,947 counties located in the United States...
kishida_japan-prime-minister
New Japanese PM Kishida Has First Call With China’s Xi
On Oct. 8, Japan’s newly elected prime minister Fumio Kishida spoke with his Chinese counterpart Xi Jinping...
China’s Pivot From a One Child Policy Forces Fertility by Means Fair or Foul
On September 27, China's State Council issued the Outline for the Development of Chinese Women (2021-...
The headquarters of Merck in Darmstadt on November 22, 2019 in Germany. Merck’s antiviral COVID-19 pill, molnupiravir, was developed with $35 million in NIH and NIAID taxpayer funding at Emory University. Now, Merck is selling it back to the government at 35 times the cost of its generic counterpart.
The NIAID and NIH Financed Development of Merck’s COVID Pill, Now They’re Selling to Taxpayers at 3,500%
Merck’s recently announced pill-based antiviral treatment for COVID-19 was researched and developed at...